Ascorbic acid in pediatric and adolescent Charcot- Marie- Tooth Disease 1A – A placebo-controlled, double-blind trial in progress

Faculty Opinions recommendation of Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160853.622273 ◽

2009 ◽

Author(s):

Davide Pareyson ◽

Chiara Marchesi

Keyword(s):

Ascorbic Acid ◽

Disease Type ◽

Efficacy Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Charcot Marie Tooth ◽

A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): The study protocol [EudraCT no.: 2006-000032-27]

Pharmacological Research ◽

10.1016/j.phrs.2006.09.001 ◽

2006 ◽

Vol 54 (6) ◽

pp. 436-441 ◽

Cited By ~ 40

Author(s):

D PAREYSON ◽

A SCHENONE ◽

G FABRIZI ◽

L SANTORO ◽

L PADUA ◽

...

Keyword(s):

Ascorbic Acid ◽

Acid Treatment ◽

Controlled Trial ◽

Disease Type ◽

Double Blind ◽

Double Blind Placebo ◽

Charcot Marie Tooth ◽

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(09)70260-1 ◽

2009 ◽

Vol 8 (12) ◽

pp. 1103-1110 ◽

Cited By ~ 85

Author(s):

Joëlle Micallef ◽

Shahram Attarian ◽

Odile Dubourg ◽

Pierre-Marie Gonnaud ◽

Jean-Yves Hogrel ◽

...

Keyword(s):

Ascorbic Acid ◽

Controlled Trial ◽

Disease Type ◽

Double Blind ◽

Double Blind Placebo ◽

Charcot Marie Tooth ◽

Ascorbic acid for Charcot–Marie–Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial

The Lancet Neurology ◽

10.1016/s1474-4422(09)70108-5 ◽

2009 ◽

Vol 8 (6) ◽

pp. 537-544 ◽

Cited By ~ 96

Author(s):

Joshua Burns ◽

Robert A Ouvrier ◽

Eppie M Yiu ◽

Pathma D Joseph ◽

Andrew J Kornberg ◽

...

Keyword(s):

Ascorbic Acid ◽

Disease Type ◽

Efficacy Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Charcot Marie Tooth ◽

Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

The Lancet Neurology ◽

10.1016/s1474-4422(11)70025-4 ◽

2011 ◽

Vol 10 (4) ◽

pp. 320-328 ◽

Cited By ~ 153

Author(s):

Davide Pareyson ◽

Mary M Reilly ◽

Angelo Schenone ◽

Gian Maria Fabrizi ◽

Tiziana Cavallaro ◽

...

Keyword(s):

Ascorbic Acid ◽

Randomised Trial ◽

Disease Type ◽

Double Blind ◽

Charcot Marie Tooth ◽

Randomised, double blind, placebo-controlled, trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A

http://isrctn.org/> ◽

10.1186/isrctn61074476 ◽

2013 ◽

Author(s):

Mary Reilly

Keyword(s):

Ascorbic Acid ◽

Acid Treatment ◽

Controlled Trial ◽

Disease Type ◽

Double Blind ◽

Double Blind Placebo ◽

Charcot Marie Tooth ◽

High-Dosage Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A

JAMA Neurology ◽

10.1001/jamaneurol.2013.3178 ◽

2013 ◽

Vol 70 (8) ◽

pp. 981 ◽

Cited By ~ 78

Author(s):

Richard A. Lewis

Keyword(s):

Ascorbic Acid ◽

Acid Treatment ◽

Disease Type ◽

Charcot Marie Tooth ◽

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Orphanet Journal of Rare Diseases ◽

10.1186/s13023-014-0199-0 ◽

2014 ◽

Vol 9 (1) ◽

Cited By ~ 59

Author(s):

Shahram Attarian ◽

Jean-Michel Vallat ◽

Laurent Magy ◽

Benoît Funalot ◽

Pierre-Marie Gonnaud ◽

...

Keyword(s):

Disease Type ◽

Phase 2 ◽

Double Blind ◽

Charcot Marie Tooth ◽

Phase 2 Study ◽

Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A (CMT1A) Trial

http://isrctn.org/> ◽

10.1186/isrctn56968278 ◽

2012 ◽

Author(s):

C. Verhamme

Keyword(s):

Ascorbic Acid ◽

Acid Treatment ◽

Disease Type ◽

Charcot Marie Tooth ◽

Comparative assessment of methylcobalamin and ascorbic acid on cognitive function in post-menopausal women - A randomized, double-blind trial

Contemporary Clinical Trials Communications ◽

10.1016/j.conctc.2017.10.006 ◽

2017 ◽

Vol 8 ◽

pp. 175-180 ◽

Cited By ~ 1

Author(s):

Thangavel Mahalingam Vijayakumar ◽

Kumaraswamy Pavitra ◽

Logaraj Muthunarayanan

Keyword(s):

Ascorbic Acid ◽

Cognitive Function ◽

Comparative Assessment ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Menopausal Women ◽

Post Menopausal